Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Naqvi (London, United Kingdom), G. D'Ancona (London, United Kingdom), A. West (London, United Kingdom). Impact of a specialist respiratory pharmacist in the management of interstitial lung disease. 3667

Member's Comments

No comment yet.

Related content which might interest you: The value of a specialist nurse-lead interstitial lung disease clinic, patients’ views Source: International Congress 2015 – Kaleidoscope of nursing research Year: 2015 Impact of early referral to palliative care in patients with interstitial lung disease Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases Year: 2021 Effects of inpatient pulmonary rehabilitation in patients with interstitial lung disease Source: Eur Respir J 2013; 42: 444-453 Year: 2013 Impact of a primary care based multidisciplinary respiratory team on hospital admission rates for patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2006 - COPD – the challenges for primary care Year: 2006 Contemporary challenges for specialist nursing in interstitial lung disease Source: Breathe, 14 (1) 36; 10.1183/20734735.014917 Year: 2018 Home management of chronic respiratory disease through the use of telemedicine Source: Annual Congress 2009 - MP18 - Home management of chronic respiratory disease through the use of telemedicine Year: 2009 Audit of acute admissions of COPD: standards of care and management in the hospital setting Source: Eur Respir J 2001; 17: 343-349 Year: 2001 Optimising inpatient resources: role of a domiciliary COPD care management programme Source: Annual Congress 2005 - Chronic care in respiratory failure Year: 2005 Current clinical guideline definitions of airflow obstruction and COPD overdiagnosis in primary care Source: Eur Respir J 2008; 32: 945-952 Year: 2008 EPIDIA: an App to to assist physicians in the care of patients with interstitial lung diseases Source: Virtual Congress 2021 – Biomarkers and e-health in idiopathic interstitial pneumonia Year: 2021 Multidisciplinary management for peadiatric chronic respiratory disease Source: Annual Congress 2004 - Psychosocial and behavioural aspects of chronic respiratory diseases Year: 2004 Out-patient pulmonary rehabilitation program reduce hospital utilisation in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 593s Year: 2002 Palliative and end-of-life care for patients with respiratory disease Source: Eur Respir Mon; 2009: 43:327–353 Year: 2009 Effect of primary-care spirometry on the diagnosis and management of COPD Source: Eur Respir J 2006; 28: 945-952 Year: 2006 Global characterisation of routine care interstitial lung disease diagnostic practice Source: International Congress 2017 – IPF: from the bench to the bedside Year: 2017 Efficacy of home-based pulmonary rehabilitation program for the patients with chronic lung diseases Source: Eur Respir J 2003; 22: Suppl. 45, 164s Year: 2003 Clinical benefits of a combined hospital and home-based exercise program in patients with interstitial lung disease Source: Eur Respir J 2006; 28: Suppl. 50, 371s Year: 2006 Effects of a comprehensive, inpatient pulmonary rehabilitation programme in a cachectic patient with very severe COPD and chronic respiratory failure Source: Breathe, 15 (3) 227; 10.1183/20734735.0186-2019 Year: 2019 Comparison of efficacy of respiratory rehabilitation in patients with COPD and interstitial lung disease Source: Annual Congress 2011 - Pulmonary rehabilitation: looking at alternative approaches and alternative populations beyond COPD Year: 2011 The role of a trained respiratory physician in lung cancer management Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology Year: 2008